Kelly Financial Services LLC Moderna, Inc. Transaction History

Kelly Financial Services LLC

$258 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$101.21 - $166.61 $10,121 - $16,661	-100 Reduced 22.52%	344 $40,000
Q1 2024 Jul 17, 2024	BUY	$85.37 - $115.44 $8,537 - $11,544	100 Added 29.07%	444 $47,000
Q4 2023 Jul 17, 2024	SELL	$69.51 - $104.43 $6,047 - $9,085	-87 Reduced 20.19%	344 $34.2 Million
Q2 2023 Jul 17, 2024	SELL	$118.5 - $160.53 $1,540 - $2,086	-13 Reduced 2.93%	431 $52.4 Million
Q1 2023 Jul 17, 2024	BUY	$135.66 - $197.02 $36,492 - $52,998	269 Added 153.71%	444 $68.2 Million
Q4 2022 Jul 17, 2024	SELL	$118.38 - $210.04 $2,959 - $5,251	-25 Reduced 12.5%	175 $31.4 Million
Q3 2022 Jul 17, 2024	BUY	$118.07 - $194.18 $2,951 - $4,854	25 Added 14.29%	200 $23.7 Million
Q1 2022 Jul 17, 2024	SELL	$126.46 - $235.05 $1,643 - $3,055	-13 Reduced 6.91%	175 $30.1 Million
Q4 2021 Jul 17, 2024	SELL	$225.82 - $368.51 $42,228 - $68,911	-187 Reduced 49.87%	188 $47.7 Million
Q3 2021 Jul 17, 2024	SELL	$221.9 - $484.47 $19.5 Million - $42.5 Million	-87,743 Reduced 99.57%	375 $144 Million
Q2 2021 Jul 17, 2024	BUY	$129.91 - $234.98 $11.4 Million - $20.6 Million	87,742 Added 23335.64%	88,118 $375,000
Q1 2021 Jul 17, 2024	SELL	$109.18 - $185.98 $982 - $1,673	-9 Reduced 2.34%	376 $49.2 Million
Q4 2020 Jul 17, 2024	BUY	$65.74 - $169.86 $7,231 - $18,684	110 Added 40.0%	385 $40.2 Million
Q3 2020 Jul 17, 2024	SELL	$54.34 - $94.85 $7,009 - $12,235	-129 Reduced 31.93%	275 $19.5 Million
Q2 2020 Jul 17, 2024	BUY	$29.67 - $80.0 $10,503 - $28,320	354 Added 708.0%	404 $25.9 Million
Q1 2020 Jul 17, 2024	BUY	$17.78 - $31.58 $889 - $1,579	50 New	50 $1.5 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Account